Digoxin treatment in heart failure--unveiling risk by cluster analysis of DIG data. - Wikidata - awgldk - TriplyDB

Digoxin treatment in heart failure--unveiling risk by cluster analysis of DIG data.

Digoxin treatment in heart failure--unveiling risk by cluster analysis of DIG data.

http://www.wikidata.org/entity/Q33578694

about

Digitalis for treatment of heart failure in patients in sinus rhythm Contemporary Controversies in Digoxin Use in Systolic Heart Failure.Outpatient management of chronic heart failure.

P2860

Q24194992-78B85310-9A36-447A-89DD-075C9BE151C8 Q38970521-7D75CF12-886B-4025-BAB6-00BDF36A0B8A Q50998627-56039054-52E9-4AB7-8AD5-520F90FE1446

P2860

Digoxin treatment in heart failure--unveiling risk by cluster analysis of DIG data.

http://www.wikidata.org/entity/Q33578694

description

2010 nî lūn-bûn

@nan

2010 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

name

Digoxin treatment in heart failure--unveiling risk by cluster analysis of DIG data.

@ast

Digoxin treatment in heart failure--unveiling risk by cluster analysis of DIG data.

@en

Digoxin treatment in heart failure--unveiling risk by cluster analysis of DIG data.

@nl

type

label

Digoxin treatment in heart failure--unveiling risk by cluster analysis of DIG data.

@ast

Digoxin treatment in heart failure--unveiling risk by cluster analysis of DIG data.

@en

Digoxin treatment in heart failure--unveiling risk by cluster analysis of DIG data.

@nl

prefLabel

Digoxin treatment in heart failure--unveiling risk by cluster analysis of DIG data.

@ast

Digoxin treatment in heart failure--unveiling risk by cluster analysis of DIG data.

@en

Digoxin treatment in heart failure--unveiling risk by cluster analysis of DIG data.

@nl

P1433

Q33578694-F905602D-7968-42CA-BD51-E2369E6BC2BF

P1476

Q33578694-5272C70B-D456-43D8-825D-8C2249B8E52C

P2093

Q33578694-0C386B15-6915-42D0-8EDE-84F1E77309A7

Q33578694-69A76E86-EB62-4CF6-8969-73B2743E7087

Q33578694-81422F71-0F41-4668-9B33-FE93E586DBE7

Q33578694-8B24E491-5F17-4B74-A88C-597CA06B36CA

Q33578694-CC789B52-782F-47A0-867B-AD84DE265D5F

Q33578694-DC9D144D-6B79-40F4-926D-8B5D0865E9BE

P2860

Q33578694-0E5FB3F9-213D-44D9-B1AA-EAD0FA70317A

Q33578694-6F02439E-B5BF-461A-8EF3-D3ACC4D50A10

Q33578694-83443622-0CD9-4112-92F4-81B8B43FC072

Q33578694-8B5C6E03-58EB-4F26-9B45-A6404C466845

Q33578694-9231BA96-75E3-4B6F-8A94-7E5BF6359975

Q33578694-A551B50F-9C42-4B27-A202-60033B370DDE

Q33578694-D4EB639D-8E97-4411-93E3-614B1E86E44C

Q33578694-DD967DC0-4C8C-4956-8467-2938AF9F28F5

P304

Q33578694-EB15AC2E-EB23-4D60-9CDE-804D15FD1B8E

P31

Q33578694-C1EB1303-8179-4C9A-8FAD-72889324A354

P356

Q33578694-2198B5F2-D16E-4106-B489-3783AECCF20E

P433

Q33578694-FB6335ED-FB8F-4824-B38E-4192DAF177BE

P478

Q33578694-A3C11E9F-00E2-4D80-8D0C-282BAAF36AA7

P50

Q33578694-169F6752-1FA6-4AAA-99BC-0460F5FB4ADE

Q33578694-36B28D13-C7BE-4D9B-B67F-68522F801D17

Q33578694-47E68ECA-76B2-418A-8196-CF1FDADF3193

Q33578694-5147E5E0-F5CD-4B3F-8253-D0E5644EC832

P577

Q33578694-E3D01563-CA6D-4673-9123-11560D8770FD

P5875

Q33578694-E68D786D-1C13-4C3B-B8DA-073008936B1F

P698

Q33578694-2CBAEA99-13EA-4568-8F0E-E80133C9CA55

P921

Q33578694-A5BEC38F-F040-4AEB-837C-26BC8DD78855

Q33578694-C7F0B12C-4FB4-4006-A420-18048A3A1279

P932

Q33578694-0BFB49E1-736D-4A7A-B063-E7FAC35D1486

P356

J.IJCARD.2010.04.021

P1433

International Journal of Cardiology

P1476

Digoxin treatment in heart failure--unveiling risk by cluster analysis of DIG data.

@en

P2093

Alvin Blaustein

http://www.w3.org/2001/XMLSchema#string

Anita Deswal

http://www.w3.org/2001/XMLSchema#string

Biykem Bozkurt

http://www.w3.org/2001/XMLSchema#string

Irakli Giorgberidze

http://www.w3.org/2001/XMLSchema#string

Kumudha Ramasubbu

http://www.w3.org/2001/XMLSchema#string

Vijay G Divakaran

http://www.w3.org/2001/XMLSchema#string

P2860

2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration

ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 G

Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial.

Digoxin and reduction of heart failure hospitalization in chronic systolic and diastolic heart failure.

Digoxin and reduction in mortality and hospitalization in geriatric heart failure: importance of low doses and low serum concentrations.

The contemporary use of digoxin for the treatment of heart failure.

Digoxin and clinical outcomes in systolic heart failure patients on contemporary background heart failure therapy.

Ethical authorship and publishing.

P304

264-269

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.IJCARD.2010.04.021

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

150

http://www.w3.org/2001/XMLSchema#string

P50

Leif E. Peterson

Douglas L. Mann

Xander H T Wehrens

P577

2010-05-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44600930

http://www.w3.org/2001/XMLSchema#string

P698

20471706

http://www.w3.org/2001/XMLSchema#string

P921

P932

2923690

http://www.w3.org/2001/XMLSchema#string